Exposure therapy in virtual reality addressing public speaking anxiety in order increase willingness for in vivo exposure in patients with anxiety disorder and obsessive-compulsive disorder
Not Applicable
- Conditions
- Phobic anxiety disordersF42F40Obsessive-compulsive disorder
- Registration Number
- DRKS00025154
- Lead Sponsor
- niversitätsklinikum Hamburg-Eppendorf
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
• Obsessive-Compulsive Disorder and/or anxiety disorder (MINI criteria)
• Gender: male, female
• Minimum Age: 18 Years
• Maximum Age: 75 Years
• Consent to participate in a single VR-session and the diagnostic interviews
• Ability to give consent
• Sufficient understanding of the German language
Exclusion Criteria
• Psychotic symptoms (current or lifetime)
• Mania
• Severe neuropsychological disease
• Current substance dependence
• Physical illnesses that are a contraindication to exposures (e.g. heart disease)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ERP Feedback Form: Self-report questionnaire to assess willingness to engage in disorder-specific in vivo exposures and to experience unpleasant feelings during these exposures, based on Reid et al. (2017). Patients report their willingness one day before (t1) and one day after (t2) the VR session. Patients' willingness is assessed on a scale ranging from 0 to 100. A further assessment will be at t4.
- Secondary Outcome Measures
Name Time Method